What Bespoke Treatment does

Bespoke Treatment is a California-based outpatient mental health treatment center specializing in treatment-resistant psychiatric conditions, founded in 2019 and headquartered in Santa Monica/Los Angeles. The clinic delivers a coordinated portfolio of neuromodulation, pharmacologic, and behavioral interventions — Transcranial Magnetic Stimulation (TMS, FDA-approved for depression and OCD since 2008), multiple ketamine delivery modalities (IV infusions, intramuscular injections, oral rapid-dissolve tablets, and FDA-approved Spravato/esketamine nasal spray), FDA-cleared Prism Neurofeedback for PTSD, Dual Sympathetic Reset stellate ganglion blocks, intensive outpatient and partial hospitalization programs (IOP/PHP), and traditional psychiatry, psychotherapy, and medication management. Bespoke was the first clinic on the West Coast to offer Prism Neurofeedback and the first in Southern California to specialize in combined TMS and ketamine therapy; a 2020 study cited in the input reported 100% remission in 28 participants receiving the combination.

The company operates four physical clinic locations across California (Los Angeles, Santa Monica, Encinitas/San Diego, Irvine) plus a virtual/telehealth service line, with total staff headcount listed in the 1-10 range. Revenue is generated predominantly through fee-for-service clinical care reimbursed by 10+ insurance networks including Cigna, Aetna, Anthem, United Healthcare, Magellan Health, Health Net, Blue California, TriWest, Enthea, and Tricare, supplemented by self-pay for ketamine and other services not covered. Distribution is direct-to-consumer via SEO-optimized content marketing, patient testimonials, an online booking system (JotForm), a Mental Health Quiz lead-generation tool, media appearances by CEO Ben Spielberg on KTLA 5, KNBC 4, and KGET, and a YouTube channel. In 2025, Bespoke Treatment merged into Stella Mental Health, a larger mental health network with cumulative outcome data from more than 20,000 treated patients; post-merger, the company's locations now operate under both the Bespoke Treatment and Stella Mental Health brands, with shared clinical protocols, marketing assets, and outcome analytics. Leadership comprises Founder/CEO Ben Spielberg (M.S., Ph.D. candidate, neuroscientist) and Chief Medical Officer Dr. Nima A. Fahimian, MD (triple board-certified, prior Cedars-Sinai Medical Director and VA chief psychiatrist). No public funding rounds, valuation events, or revenue disclosures are present in the source material.

Name

Bespoke Treatment

Legal name

Bespoke Treatment, LLC

Website

https://bespoketreatment.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Bespoke Treatment is a California-based outpatient mental health clinic specializing in treatment-resistant depression, anxiety, OCD, and PTSD through TMS, ketamine therapy, Spravato, Prism Neurofeedback, and psychiatry services across four locations plus virtual care, now part of the Stella Mental Health network.

Ownership category

akta.pro rank

Product category

Mental Health Treatment Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)

akta.pro secondary industries

Psychiatry & Medication Management Platforms (HLALAEAB), General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)

Keywords

• Mental health treatment
• Psychiatric services
• TMS therapy
• Ketamine therapy
• Neurofeedback treatment

Headquarters

HQ city

Santa Monica

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Mental Health Treatment Services: Revenue generated from providing mental health treatments including TMS therapy, ketamine infusions, Spravato, neurofeedback, psychiatry evaluations, medication management, and intensive outpatient programs. Services are billed to insurance or paid directly by patients. Insurance coverage varies by provider and plan, with TMS typically covered by major insurance companies.
2. Insurance Reimbursement: Bespoke Treatment accepts multiple insurance providers including Health Net, Cigna, Blue California, Aetna, Magellan Health, Anthem, United Healthcare, TriWest, Enthea, and Tricare. Many insurance plans cover TMS Therapy, and Spravato is FDA-approved making it more likely to be covered by insurance.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Bespoke Treatment is a mental health treatment center providing outpatient psychiatric care including Transcranial Magnetic Stimulation (TMS) therapy, Ketamine Treatment (IV infusions, injections, assisted therapy, oral rapid dissolve tablets), FDA-approved Spravato (esketamine nasal spray), Prism Neurofeedback for PTSD, Dual Sympathetic Reset (SGB), traditional psychiatry evaluations, psychotherapy, medication management, and intensive outpatient programs (IOP/PHP). Services are delivered through in-person clinics in California and virtual telehealth consultations, with billing through major insurance providers.

Product overview

Bespoke Treatment is a mental health treatment center offering a coordinated suite of therapeutic services centered around innovative neuromodulation and pharmacological treatments. The core portfolio includes TMS Therapy (Transcranial Magnetic Stimulation) and Ketamine Treatment (with infusions, assisted therapy, and oral formulations), supported by FDA-approved Spravato (esketamine nasal spray). Additional offerings include Prism Neurofeedback (FDA-cleared EEG-based PTSD treatment), Dual Sympathetic Reset (SGB injections), Intensive Outpatient Programs (IOP/PHP), and traditional Psychiatry/Psychotherapy services. The company also provides a Mental Health Quiz as an initial assessment tool. These services are designed to work together—particularly the synergistic combination of TMS and ketamine—offering individualized treatment plans for treatment-resistant depression, anxiety, OCD, PTSD, and mood disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• TMS Therapy Non-invasive procedure using targeted magnetic pulses to stimulate nerve cells in the brain involved in mood regulation. FDA-approved for depression and OCD, also used for anxiety, PTSD, and other mood disorders.
• Ketamine Treatment Fast-acting relief from treatment-resistant depression, OCD, and trauma-related symptoms. Available as IV infusions, intramuscular injections, and oral rapid dissolve tablets (RDTs), administered under medical supervision.
• Spravato (Esketamine Nasal Spray) FDA-approved nasal spray containing esketamine for treatment-resistant depression and suicidal ideation. The only insurance-backed form of ketamine, administered in-clinic under supervision with the REMS program.
• Psychiatry Board-certified psychiatric evaluations, diagnoses, and medication management for treatment-resistant mental health disorders, including comprehensive assessment and individualized treatment planning.
• Prism Neurofeedback FDA-cleared neurofeedback device using real-time EEG brain activity displays to teach self-regulation for PTSD symptoms. A medication-free psychiatric intervention that trains patients to control amygdala-based biomarkers through visual feedback.
• Dual Sympathetic Reset (DSR SGB) A procedure where local anesthetic is injected next to the stellate ganglion to help regulate involuntary functions such as heart rate, blood pressure, and sweating, addressing sympathetic nervous system overactivity.
• Intensive Outpatient Program (IOP) Mental health outpatient programs combining holistic and evidence-based modalities including intensive outpatient program (IOP) and partial hospitalization program (PHP) for comprehensive treatment.
• Ketamine Infusions Intravenous ketamine administration in a serene private setting under strict medical supervision for treatment-resistant mental health conditions.
• Ketamine Assisted Therapy Combines ketamine administration with therapeutic support, maximizing therapeutic value by capturing experiences during treatment and developing individualized plans to put insights into action.
• Accelerated TMS An accelerated version of transcranial magnetic stimulation therapy designed to provide more intensive treatment over a compressed timeframe.
• Psychotherapy Therapeutic sessions that maximize the therapeutic value of biological treatment by capturing experiences that surface during and after treatment, making meaning of insights, and developing specific individualized plans.
• Medication Management Psychiatric medication management services including evaluation, prescribing, and ongoing monitoring of psychiatric medications.
• Clinical Trials Access to clinical trials for patients interested in participating in research studies for emerging psychiatric treatments.

Quantifiable outcome

• 88% reduction in depression scores
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Stella Mental HealthcoreStrategic or Co-development PartnerBespoke Treatment has joined Stella Mental Health, a larger mental health network. The partnership combines approaches that are deeply aligned to expand access to a broader range of research-backed treatments. Bespoke Treatment locations now operate under the Stella Mental Health brand, with shared resources including a network of 20,000+ treated patients for outcome data and expanded treatment options.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Charlie Health: Multi-state intensive outpatient (IOP) and virtual mental health provider focused on adolescents, young adults, and adults with depression, anxiety, and trauma. Comparable in operating intensive outpatient programs and combining insurance-reimbursed care with technology-enabled intake/engagement tools.
• Mindful Health Solutions: Bay Area-based psychiatric practice operating multiple California clinics focused on TMS, ketamine, and medication management for treatment-resistant depression and anxiety. It is the closest direct competitor to Bespoke in terms of treatment modality mix, geographic overlap in California, and insurance-reimbursed service model.
• Pasternack Psychological Associates / Pacific Anxiety Group: Southern California anxiety and OCD specialty practice offering TMS, exposure therapy, and medication management for anxiety-related disorders. Similar specialty positioning in treatment-resistant anxiety/OCD and parallel in-clinic neuromodulation + therapy model.
• Nue Life Holdings: Ketamine-assisted therapy provider offering both clinic-based infusions and digital/telehealth follow-up programs for treatment-resistant mental health conditions. Direct overlap in ketamine-based protocols and combination of in-person plus virtual mental health delivery.
• Field Trip Health & Wellness (historical): Was a publicly traded ketamine-assisted therapy clinic operator with multi-city footprint and combined ketamine + integration therapy model. Closest historical direct peer in ketamine clinic model; serves as a cautionary comparable given its post-SPAC contraction and North American restructuring.

Broad incumbents

• Lyra Health: Enterprise mental-health benefits platform connecting employees to therapy, coaching, and medication management with a hybrid in-person/virtual provider network. Comparable as a scaled, employer- and insurance-paid mental health delivery platform sitting adjacent to Bespoke's in-clinic specialty services.
• Cerebral: National tele-mental-health platform providing psychiatric evaluation, medication management, and therapy under an insurance/consumer-hybrid model. Comparable as a broad mental-health incumbent pivoting toward in-person hybrid delivery and outcomes-oriented psychiatric care.
• Stella Mental Health: Parent mental-health network that Bespoke joined in 2025, operating clinics across multiple states offering TMS, ketamine, Spravato, neurofeedback, and IOP services. It is now both the parent and a sibling operator with broad geographic reach and shared clinical protocols.
• Talkspace: Public online therapy and psychiatry platform delivering virtual talk therapy and medication management to insured and self-pay consumers. Overlaps with Bespoke's telehealth psychiatry and therapy service lines, though Talkspace is a broader and consumer-facing delivery model.

Regional players

• Compass Behavioral Health: Multi-state outpatient mental-health and substance-use treatment provider offering psychiatric care, therapy, IOP/PHP, and TMS. Comparable in modality mix (TMS plus IOP plus psychiatry) and outpatient-only delivery model, but concentrated in different geographic regions than Bespoke.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@StellaMentalHealth
• LinkedInlinkedin.com/company/tms-brain-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bespoke Treatment